These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22791168)

  • 21. Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs.
    Tassone EJ; Sciacqua A; Andreozzi F; Presta I; Perticone M; Carnevale D; Casaburo M; Hribal ML; Sesti G; Perticone F
    Cardiovasc Res; 2013 Jul; 99(1):129-36. PubMed ID: 23524303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of steroidogenic acute regulatory protein in rat aortic endothelial cells attenuates palmitic acid-induced inflammation and reduction in nitric oxide bioavailability.
    Tian D; Qiu Y; Zhan Y; Li X; Zhi X; Wang X; Yin L; Ning Y
    Cardiovasc Diabetol; 2012 Nov; 11():144. PubMed ID: 23170972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II type 1 receptor, but no type 2 receptor, interferes with the insulin-induced nitric oxide production in HUVECs.
    Presta I; Tassone EJ; Andreozzi F; Perticone M; Sciacqua A; Laino I; Musca D; Martino F; Sesti G; Perticone F
    Atherosclerosis; 2011 Dec; 219(2):463-7. PubMed ID: 21937042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-6 inhibits endothelial nitric oxide synthase activation and increases endothelial nitric oxide synthase binding to stabilized caveolin-1 in human vascular endothelial cells.
    Hung MJ; Cherng WJ; Hung MY; Wu HT; Pang JH
    J Hypertens; 2010 May; 28(5):940-51. PubMed ID: 20375905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta.
    Kim F; Tysseling KA; Rice J; Pham M; Haji L; Gallis BM; Baas AS; Paramsothy P; Giachelli CM; Corson MA; Raines EW
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):989-94. PubMed ID: 15731493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein CIII links hyperlipidemia with vascular endothelial cell dysfunction.
    Kawakami A; Osaka M; Tani M; Azuma H; Sacks FM; Shimokado K; Yoshida M
    Circulation; 2008 Aug; 118(7):731-42. PubMed ID: 18663085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dihydrohomoplantagin and Homoplantaginin, Major Flavonoid Glycosides from
    Meng N; Chen K; Wang Y; Hou J; Chu W; Xie S; Yang F; Sun C
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 20-Hydroxyeicosatetraenoic acid impairs endothelial insulin signaling by inducing phosphorylation of the insulin receptor substrate-1 at Ser616.
    Li X; Zhao G; Ma B; Li R; Hong J; Liu S; Wang DW
    PLoS One; 2014; 9(4):e95841. PubMed ID: 24763529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Puerarin attenuates endothelial insulin resistance through inhibition of inflammatory response in an IKKβ/IRS-1-dependent manner.
    Huang F; Liu K; Du H; Kou J; Liu B
    Biochimie; 2012 May; 94(5):1143-50. PubMed ID: 22314193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis.
    Choi YJ; Yoon Y; Lee KY; Hien TT; Kang KW; Kim KC; Lee J; Lee MY; Lee SM; Kang DH; Lee BH
    FASEB J; 2014 Jul; 28(7):3197-204. PubMed ID: 24652948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-reactive protein suppresses insulin signaling in endothelial cells: role of spleen tyrosine kinase.
    Xu JW; Morita I; Ikeda K; Miki T; Yamori Y
    Mol Endocrinol; 2007 Feb; 21(2):564-73. PubMed ID: 17095576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PPARβ activation restores the high glucose-induced impairment of insulin signalling in endothelial cells.
    Quintela AM; Jiménez R; Piqueras L; Gómez-Guzmán M; Haro J; Zarzuelo MJ; Cogolludo A; Sanz MJ; Toral M; Romero M; Pérez-Vizcaíno F; Duarte J
    Br J Pharmacol; 2014 Jun; 171(12):3089-102. PubMed ID: 24527778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective Effects of Total Saponins of
    Zhou P; Xie W; Luo Y; Lu S; Dai Z; Wang R; Sun G; Sun X
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells.
    Aragonès G; Saavedra P; Heras M; Cabré A; Girona J; Masana L
    Cardiovasc Diabetol; 2012 Jun; 11():72. PubMed ID: 22709426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TRIB3 R84 variant is associated with impaired insulin-mediated nitric oxide production in human endothelial cells.
    Andreozzi F; Formoso G; Prudente S; Hribal ML; Pandolfi A; Bellacchio E; Di Silvestre S; Trischitta V; Consoli A; Sesti G
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1355-60. PubMed ID: 18436806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tetramethylpyrazine attenuates TNF-α-induced iNOS expression in human endothelial cells: Involvement of Syk-mediated activation of PI3K-IKK-IκB signaling pathways.
    Zheng Z; Li Z; Chen S; Pan J; Ma X
    Exp Cell Res; 2013 Aug; 319(14):2145-51. PubMed ID: 23726836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells.
    Federici M; Pandolfi A; De Filippis EA; Pellegrini G; Menghini R; Lauro D; Cardellini M; Romano M; Sesti G; Lauro R; Consoli A
    Circulation; 2004 Jan; 109(3):399-405. PubMed ID: 14707024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of paeoniflorin on tumor necrosis factor-α-induced insulin resistance and changes of adipokines in 3T3-L1 adipocytes.
    Kong P; Chi R; Zhang L; Wang N; Lu Y
    Fitoterapia; 2013 Dec; 91():44-50. PubMed ID: 23978582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of IKKbeta by glucose is necessary and sufficient to impair insulin signaling and nitric oxide production in endothelial cells.
    Kim F; Tysseling KA; Rice J; Gallis B; Haji L; Giachelli CM; Raines EW; Corson MA; Schwartz MW
    J Mol Cell Cardiol; 2005 Aug; 39(2):327-34. PubMed ID: 15978611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological activation of PPAR gamma ameliorates vascular endothelial insulin resistance via a non-canonical PPAR gamma-dependent nuclear factor-kappa B trans-repression pathway.
    Zhang Y; Zhan RX; Chen JQ; Gao Y; Chen L; Kong Y; Zhong XJ; Liu MQ; Chu JJ; Yan GQ; Li T; He M; Huang QR
    Eur J Pharmacol; 2015 May; 754():41-51. PubMed ID: 25687252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.